Skip to search formSkip to main contentSkip to account menu

LY 393558

Known as: 1-(2-(4-(6-fluoro-1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl)ethyl)-3-isopropyl-6-(methylsulfonyl)-3,4-dihydro-1H-2,1,3-benzothiadiazine-2,2-dioxide, LY-393558, LY393558 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Cyclic S-OxidesSerotonin AntagonistsThiadiazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Reduction of the serotonin 5-HT1B and 5-HT2A receptor-mediated contraction of human pulmonary artery by the combined 5-HT1B receptor antagonist and serotonin transporter inhibitor LY393558
LY393558 is a combined antagonist of serotonin (5-HT) 5-HT1B receptors and inhibitor of serotonin transporter (SERT). LY393558… 
2013
2013
Influence of LY393558 — a combined 5-HT_1B receptor antagonist and serotonin transporter inhibitor — on the contractile responses of serotonin in human pulmonary arteries
2009
2009
Combined Serotonin Transporter and 5-HT1BReceptor Inhibitor LY393558 Reverses Established Pulmonary Hypertension (PAH) in Mice.
2009
2009
Combined Serotonin Transporter and 5-HT1BReceptor Inhibitor LY393558 Prevents Pulmonary Hypertension (PAH) in Two Models of PAH.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)